Ocugen plans $16.5M stock sale, share price plunges

The announcement of the public stock sale comes about three weeks after Ocugen disclosed it had halted work on Covaxin, a Covid-19 vaccine from India that it spent more than two years trying to bring to the United States.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news